Tetrahydrouridine
英文名称: Tetrahydrouridine
型号:null    产品货号: IEN1601-0010MG
价格:请致电:010-57128832,18610462672
品牌: gene operation

 IEN1601-Tetrahydrouridine

Tetrahydrouridine≥85%

【英文同义名】:3, 4, 5, 6-Tetrahydrouridine, THU, H4Urd, NSC-112907

【中文同义名】:四氢尿苷

订购信息:(原装进口,常备现货)

 

产品名称

产品货号

目录价(元)

Gene Operation

Tetrahydrouridine

IEN1601-0010MG

10 mg

¥1,629.00

产品描述

嘧***核苷类似物四氢尿苷(Tetrahydrouridine, THU)是一种有效的胞苷脱氨酶(CDA)抑制剂,Ki值为2.4×10-7 M。竞争性阻断酶活性位点,比作用于内源性胞嘧***的活性更强 [1]THU是一种强力的多药耐药性调节剂和***线增敏剂。体内外研究中,常与胞苷类似物,如5-氮杂胞苷[2],阿糖胞苷(Ara-C) [3],吉西他滨 (dFdC)[4],和地西他滨[5]联合使用,因为四氢尿苷能够维持这些药物的半衰期,从而临床前和临床实验中增强以上药物的抗肿瘤特性。

靶点

靶点

CDA

IC50(半数有效浓度)

2.4×10-7 M (Ki) [1]

化学特性

Cas No.: 18771-50-1

分子量: 248.2

分子式: C9H16N2O6

纯度: ≥85%

同义名: 3, 4, 5, 6-Tetrahydrouridine, THU, H4Urd, NSC-112907

化学名: 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one

外观: White to off-white solid

溶解: 溶于Water (up to 100 mM)

保存::3 -20℃粉状

储存液配制

储存液 (1 ml H2O体系)

1 mM

5 mM

10 mM

25 mM

50 mM

100 mM

质量(mg)

0.2482

1.2410

2.4820

6.2050

12.4100

24.8200

结构式

                       

使用浓度(仅作参考)

Tetrahydrouridine具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。

参考文献

[1] Cohen RM, et al. Cytidine deaminase from Escherichia coli: purification, properties and

inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine. J Biol Chem. 246(24): 7561–5 (1971).

[2] Neil GL, et al. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. Cancer Chemother Rep. 59(3):459–65 (1975).

[3] Riccardi R, et al. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. Cancer Res. 42(5):1736-9 (1982).

[4] Beumer JH, et al. Modulation of gemcitabine (2,2-difluoro-2-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. Clin Cancer Res. 14(11):3529-35 (2008).

[5] Lavelle D, et al. Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 119(5):1240-7 (2012).